Cero Therapeutics presents preclinical data on CER-1236 at SITC Spring meeting
CERo Therapeutics (CERO) presented preclinical results of lead compound CER-1236 in ovarian cancer during the 2025 SITC Spring Scientific ...
Ovarian cancer patients in Somerset beating the odds with top care
Somerset is proving that world-class ovarian cancer care is not just for big cities, with local survival rates now among the ...
Medscape20h
Endometrial Cancer: Molecular Classification, Genetics, When to Rebiopsy, and What's New in the Research
Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.
Multiple Sclerosis News Today17h
Epstein-Barr virus may drive MS by dysregulating certain immune cells
Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says ...